Bone Marrow Transplant - Children

Text Size A A

E-Mail to a Friend



secret  Click to Play Audio


Send To Friend

Our Expertise

At the SCCA Pediatric Transplant Program, your child will get the newest forms of therapy from the world’s top experts in pediatric cancers, blood disorders, and transplantation. Forty years ago, we pioneered bone marrow transplantation for children. Today we are still creating the boldest new treatments for children.

With every patient, we push for a perfect transplant and follow-up care. And every day, because of our experience, research, and commitment, we inch closer to our goal: a safe procedure, a lifesaving cure, and a long healthy life for every child who comes to us.

At SCCA, your child will receive excellent, world-class medical care in an environment designed to support your child and your entire family.

Facts about the Fred Hutchinson Pediatric Transplant Program at SCCA:

  • We have performed more than 2,300 bone marrow transplants in children and teens.
  • Every year, we do about 50 bone marrow transplants in children and teens.
  • Our team includes over a dozen physician specialists in pediatric hematology, oncology, and transplantation plus a large staff of pediatric nurse practitioners, pediatric nurses, physician assistants, social workers, dietitians, and other special care providers.
  • Our transplant results are exceptional even though we treat high-risk patients. Overall, 100-day survival for pediatric transplantations done in 2005-2009 was 96%, 96%, 94%, 91%, and 92%; 1-year survival in the same years was 82%, 89%, 76%, 81%, and 78%.
  • We created special techniques for children who lack matched donors; for example, our haploidentical (half-matched) program allows parents and most siblings to donate.
  • SCCA results after unrelated donor transplants are outstanding; we consistently rank among the top U.S. transplant centers in 1-year survival rates for these more difficult procedures (see CIBMTR/NMDP study); in children at SCCA, our recent 1-year survival rate was 77% after unrelated donor transplant (see NMDP website)
  • We offer new procedures to reduce the side effects of conditioning.
  • Our special way of preparing cord blood improves results in stem cell transplants.
  • Increasingly, we use transplants to help children with noncancer diseases such as immune disorders, blood diseases, and other serious illness.
  • We stay in touch with children and parents long after the transplant; this helps to avoid potential problems and to ensure long-term health.
10-21-2008   Final Report of Center-Specific Survival Rates in NMDP Facilitated Transplants (338kb)